Investors: Viking Global Investors, MVM Partners, Gilde Healthcare, Evidity Health Capital, Medtech Venture Partners, FemHealth Ventures
GT Medical Technologies, a medical device company developing GammaTile bioresorbable radiotherapy implants for brain tumors, raised $100 million in a Series E to accelerate commercial expansion following successful ROADS trial data.